NSE: MUKKA · BSE: 544135 · ISIN INE0CG401037
Mukka Proteins Limited stock analysis
Mukka Proteins Limited ranks #3885 in the TickerSutra evidence-ranked universe with a score of 37/100 and 91% data confidence. The latest captured fundamentals show ROCE of 11.6%, quarterly sales growth of 186.7% and quarterly profit growth of 1142.8%.Avoid / exit review
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- Debt/equity is above 0.5×
- CFO/EBITDA is below 0.6×
- Extreme base-effect growth requires manual validation
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹770cr | ₹48cr | ₹26cr | 6.0% |
| 2023 | ₹1,177cr | ₹86cr | ₹48cr | 7.0% |
| 2024 | ₹1,380cr | ₹105cr | ₹74cr | 8.0% |
| 2025 | ₹1,006cr | ₹95cr | ₹48cr | 9.0% |
| 2026 | ₹1,449cr | ₹115cr | ₹57cr | 8.0% |
| TTM | ₹1,768cr | ₹147cr | ₹74cr | 8.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Mukka Proteins Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
RoutineAnalyst/Investor Meet Para A-XBRLNSE · 23 Sept 2026 · Structured filingMUKKA PROTEINS LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet
MUKKA PROTEINS LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet
Open original XBRL sourceIntimation of the schedule of Analyst/Investor meeting.
RoutineAnalyst/Investor Meet Para A-XBRLNSE · 12 Sept 2026 · Structured filingMUKKA PROTEINS LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet
MUKKA PROTEINS LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet
Open original XBRL sourceMukka Proteins Limited has informed the Exchange about Schedule of Investor meet to be held on 17th September 2026
MANAGEMENT COMMENTARY
Signals from filed documents
For Mukka Proteins, sustainability is embedded across our operations through responsible marine sourcing, waste-to- value initiatives, alternate proteins and environmental solutions. Outlook: Disciplined Growth amid Climate and Commodity Volatility We remain committed to our ambition of exceeding ₹3,000 crore in revenue by FY30, supported by organic growth, capacity expansion, value-added products, international expa
Refinancing risk given elevated leverage; currency risk given high export mix. OUTLOOK Management has articulated an aspiration to more than double consolidated revenue from ₹1,449 crore in FY26 to over ₹3,000 crore by FY30, driven by continued integration across the Company's four verticals, disciplined organic and inorganic expansion (including the Oman and Sri Lanka initiatives), and backward integration into fish
The summit offered valuable insights into evolving market trends, strengthened strategic relationships and opened new avenues for collaboration. Our presence at this prestigious event reaffirmed our commitment to sustainable growth, innovation, and global market leadership in the animal nutrition industry. IFFO CHINA SUMMIT 2026 IFFO CHINA SUMMIT 2026 IFFO MEMBER’S MEETING 2026 IFFO MEMBER’S MEETING 2026 Mukka Protei
While climate-related events such as El Niño may create both opportunities and challenges for the marine-ingredients industry, we believe our diversified business model, international presence, alternate-protein platform and disciplined operating approach position us well for long-term growth. Alongside growth, we remain focused on cost optimization, deleveraging, working-capital discipline and prudent capital alloca
The confirmation received from Global Trust Certification, NSF, Ireland, enhances the Company’s alignment with international sustainability and responsible sourcing standards. This development is expected to improve supply chain transparency, reduce sourcing risks through traceable and fishery improvement programme-linked supply chains, and support compliance with global standards, thereby enhancing the Company’s bra
The renewed consent, valid from 12 November 2025 to 30 September 2032, permits the Company to lawfully operate its industrial activities in compliance with prescribed environmental norms. This approval reinforces the Company’s adherence to regulatory standards relating to effluent treatment, emission-control systems and pollution-prevention measures, thereby supporting continuity of operations and strengthening its e
Policy has provided a consistent tailwind: the Swachh Bharat Mission (and its second phase, SBM 2.0, targeting “garbage- free” cities and the scientific remediation of legacy dumpsites), the Solid Waste Management Rules, 2016 (with updated rules mandating multi-stream segregation taking effect through 2026), and a series of state- and city-level programmes have collectively lifted the share of MSW scientifically proc
In all interactions with institutional investors and financial analysts, the Company ensures that no unpublished price-sensitive information is shared or discussed. The quarterly / half yearly / annual financial results and other communication including official news release to shareholders and Stock Exchanges, inter-alia, presentations to institutional investors & analysts, press releases, etc., are made available o
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…